GE HEALTHCARE TECHNOLOGY (GEHC) Stock Price, Quote, News and Overview
NASDAQ:GEHC - Nasdaq - US36266G1076 - Common Stock - Currency: USD
GEHC Quote, Performance and Key Statistics
67.67
-2.66 (-3.78%)
The current stock price of GEHC is 67.67 USD. In the past month the price decreased by -14.73%. In the past year, price decreased by -14.85%.
GEHC Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.38 | 226.99B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.69 | 185.29B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.22 | 152.63B | ||
| SYK | STRYKER CORP | 30.68 | 142.75B | ||
| MDT | MEDTRONIC PLC | 15.65 | 107.17B | ||
| BDX | BECTON DICKINSON AND CO | 12.19 | 48.68B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.92 | 44.20B | ||
| IDXX | IDEXX LABORATORIES INC | 41.9 | 38.20B | ||
| RMD | RESMED INC | 26.05 | 34.73B | ||
| DXCM | DEXCOM INC | 42.58 | 27.55B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.81 | 23.48B | ||
| STE | STERIS PLC | 24.21 | 21.84B |
Related stock screener links
About GEHC
Company Profile
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 53,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Company Info
GE HEALTHCARE TECHNOLOGY
500 West Monroe Street
Chicago ILLINOIS US
Employees: 51000
Company Website: https://www.gehealthcare.com
Investor Relations: https://investor.gehealthcare.com/
Phone: 18337351139
GE HEALTHCARE TECHNOLOGY / GEHC FAQ
What is the stock price of GE HEALTHCARE TECHNOLOGY today?
The current stock price of GEHC is 67.67 USD. The price decreased by -3.78% in the last trading session.
What is the ticker symbol for GE HEALTHCARE TECHNOLOGY stock?
The exchange symbol of GE HEALTHCARE TECHNOLOGY is GEHC and it is listed on the Nasdaq exchange.
On which exchange is GEHC stock listed?
GEHC stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for GE HEALTHCARE TECHNOLOGY stock?
26 analysts have analysed GEHC and the average price target is 99.45 USD. This implies a price increase of 46.96% is expected in the next year compared to the current price of 67.67. Check the GE HEALTHCARE TECHNOLOGY stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GE HEALTHCARE TECHNOLOGY worth?
GE HEALTHCARE TECHNOLOGY (GEHC) has a market capitalization of 30.98B USD. This makes GEHC a Large Cap stock.
How many employees does GE HEALTHCARE TECHNOLOGY have?
GE HEALTHCARE TECHNOLOGY (GEHC) currently has 51000 employees.
What are the support and resistance levels for GE HEALTHCARE TECHNOLOGY (GEHC) stock?
GE HEALTHCARE TECHNOLOGY (GEHC) has a support level at 62.21 and a resistance level at 70.33. Check the full technical report for a detailed analysis of GEHC support and resistance levels.
Is GE HEALTHCARE TECHNOLOGY (GEHC) expected to grow?
The Revenue of GE HEALTHCARE TECHNOLOGY (GEHC) is expected to grow by 1.65% in the next year. Check the estimates tab for more information on the GEHC EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GE HEALTHCARE TECHNOLOGY (GEHC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GEHC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GEHC, evaluating the profitability, health, valuation and growth aspects
- GE HEALTHCARE TECHNOLOGY (GEHC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GE HEALTHCARE TECHNOLOGY (GEHC) Sales and EPS estimates to see what analysts future expectations are.
- GE HEALTHCARE TECHNOLOGY (GEHC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GE HEALTHCARE TECHNOLOGY (GEHC) Insider and Institutional Ownership to learn about the owners and their transactions.
- GE HEALTHCARE TECHNOLOGY (GEHC) Stock Chart to make your own analysis
- GE HEALTHCARE TECHNOLOGY (GEHC) Latest news and press-releases to stay up to date.
Does GE HEALTHCARE TECHNOLOGY (GEHC) stock pay dividends?
GE HEALTHCARE TECHNOLOGY (GEHC) has a dividend yield of 0.21%. The yearly dividend amount is currently 0.12. Check the full fundamental report for a detailed analysis of GEHC dividend history, reliability and sustainability.
What is the Price/Earnings (PE) ratio of GE HEALTHCARE TECHNOLOGY (GEHC)?
The PE ratio for GE HEALTHCARE TECHNOLOGY (GEHC) is 14.71. This is based on the reported non-GAAP earnings per share of 4.6 and the current share price of 67.67 USD. Check the full fundamental report for a full analysis of the valuation metrics for GEHC.
What is the Short Interest ratio of GE HEALTHCARE TECHNOLOGY (GEHC) stock?
The outstanding short interest for GE HEALTHCARE TECHNOLOGY (GEHC) is 1.8% of its float. Check the ownership tab for more information on the GEHC short interest.
GEHC Technical Analysis
GEHC Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to GEHC. GEHC scores excellent on profitability, but there are concerns on its financial health.
GEHC Financial Highlights
Over the last trailing twelve months GEHC reported a non-GAAP Earnings per Share(EPS) of 4.6. The EPS increased by 15.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.13% | ||
| ROA | 6.02% | ||
| ROE | 23.6% | ||
| Debt/Equity | 0.89 |
GEHC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 79% to GEHC. The Buy consensus is the average rating of analysts ratings from 26 analysts.
For the next year, analysts expect an EPS growth of 6.62% and a revenue growth 1.65% for GEHC